Suzhou Basecare Medical's (HKG:2170) subsidiary Genea Biomedx agreed to cooperate with Rhea Labs to establish model artificial intelligence-powered in vitro fertilization clinics.
The five-year strategic cooperation will see the parties jointly expand the assisted reproductive industry markets across the US, Europe, South America, and Southeast Asia, a Tuesday bourse filing said.
Under the tie-up, Genea Biomedx will provide medical products and comprehensive solutions to support the development of Rhea Labs' reproductive institutions and jointly collaborate to develop AI-powered new products.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。